Top Female Condom Brands to Enhance Pleasure and Safety

In recent years, female condoms have gained significant recognition as an empowering choice for safer sex, providing women with more control over their reproductive health. Offering both comfort and efficacy, modern female condoms are designed to enhance pleasure while ensuring protection against sexually transmitted infections and unwanted pregnancies. Several brands have emerged as leaders in the market, each catering to diverse preferences and needs, with options that prioritize material quality, ease of use, and affordability. To discover a comprehensive list of the best brands for female condoms, read on below.

Illustration of female condoms

Best brands of female condoms in 2025

FC2 Female Condom

The FC2 Female Condom, produced by Veru Inc., is a leading and FDA-approved single-use internal condom, distributed in 150 countries, including the U.S., and has sold over 750 million units worldwide. Made from nitrile polymer, it is stronger than latex, reduces the risk of tearing, and can be used with both oil and water-based lubricants. It provides protection against pregnancy, STIs, and HIV/AIDS, and can be inserted up to 8 hours before intercourse. The FC2 has been shown to have significant benefits, especially in developing countries with high demand due to its effectiveness in preventing unintended pregnancies and STIs. It is also covered by most insurance companies under the Affordable Care Act. For more information, visit the FC2 Female Condom product page.

VivaGel® Condom

The VivaGel^(r) Condom, developed by Starpharma and marketed by Ansell under the LifeStyles^(r) Dual Protect^(tm) brand, is a groundbreaking product that combines barrier protection with an antiviral compound, astodrimer sodium (SPL7013), which has been proven in laboratory studies to inactivate up to 99.9% of HIV, HSV, and HPV. Launched in Canada in 2017 and Australia in 2014, this condom is the first of its kind, offering enhanced protection against sexually transmitted infections. The VivaGel^(r) active has shown significant antiviral efficacy, making it a leading innovation in sexual health products. This collaboration between Starpharma and Ansell highlights their commitment to providing innovative solutions for safety and well-being. The product is available in various retail outlets and online platforms, including Amazon.ca.

Cupid Female Condom

Cupid Limited is a leading manufacturer of female condoms, distinguished by its high-quality products approved by prestigious bodies like the USFDA and WHO. The company has seen significant growth, particularly with its female condom segment, which has margins three times higher than male condoms and contributed 17% to the product mix in Q2FY23, up from 13% in the previous year. Cupid's female condoms are made from natural rubber latex and feature a polyurethane foam internal retainer, enhancing user experience and safety. The company has secured substantial export orders, including a notable order from South Africa worth Rs103 crores, which is expected to contribute significantly to their revenue over the next three years. With a strong focus on innovation and quality, Cupid Limited continues to be a major player in the global female condom market.

Woman's Condom

The Woman's Condom, developed by the global health nonprofit PATH, is a highly innovative and user-friendly female condom designed to enhance acceptability, ease of use, and sexual sensation. This condom is made from polyurethane and features a unique capsule that dissolves quickly after insertion, releasing the pouch which is then secured by foam pads. It is packaged dry and comes with a water-based lubricant, making it convenient and effective. With its user-centered design, the Woman's Condom aims to improve the 95% effectiveness rate of female condoms when used correctly, and it is currently in early introduction phases. The Woman's Condom is manufactured by Shanghai Dahua Medical Apparatus in China and is under review by the World Health Organization. For more information, you can read about The Woman's Condom on Wikipedia.

Origami Female Condom

The Origami Internal Condom (OIC) is a cutting-edge, partner-initiated female condom designed to enhance sensation, improve ease of use, and ensure safety by minimizing slipping and breaking. Developed by Origami Condoms in the United States, the OIC is made from a unique, anatomy-specific material that is 100% biocompatible and non-allergenic. Although it was expected to hit the market in late 2016, it is still pending regulatory pre-market reviews with the CE Mark, WHO, and the US FDA. The OIC aims to replicate a natural intercourse experience and is intended for contraception and the prevention of HIV and other STIs. Its innovative design sets it apart as a promising product in the growing female condom market. For more information about this groundbreaking product, visit the Origami Internal Condom page on Cervical Barriers.

VA w.o.w. Condom Feminine

The VA w.o.w. Condom Feminine, manufactured by HLL Lifecare Ltd. and IXu LLC, is a notable brand in the female condom market, known for its latex construction and innovative design featuring a pouch and sponge for secure placement. This condom has received the CE mark, indicating it meets European Union consumer health requirements, and is distributed in several regions including the EU, South Africa, Brazil, and India. The VA w.o.w. Condom Feminine is designed for improved acceptability, ease of use, and enhanced sensation, making it a preferred choice for many users. It is part of the growing female condom segment, which is expected to register significant growth due to increasing acceptance and demand for female-controlled barrier methods. The global health nonprofit PATH and other organizations have also recognized the importance of such products in reducing the risk of STDs and unplanned pregnancies.

Velvet Female Condom

The Velvet Female Condom is a highly regarded product in the female condom market, demonstrated by its noninferiority to the established FC2 female condom in a clinical trial. This study, involving 300 women, showed that the Velvet Female Condom had a total clinical failure rate of 3.93%, which is comparable to the FC2's 4.50% and the Cupid2's 4.79%. The trial confirmed that the Velvet Female Condom meets the necessary safety and performance standards, supporting its prequalification submission to the World Health Organization (WHO) and the United Nations Population Fund (UNFPA). This product innovation is part of the broader efforts to increase consumer choice and competition in the female condom market, which has seen significant growth and innovation since the mid-2000s. The Velvet Female Condom's performance and safety make it a valuable option for women seeking dual protection against STIs and unwanted pregnancy. For more detailed information, you can refer to the clinical trial study that highlights its efficacy and comparability.

Phoenurse Female Condom

The Phoenurse Female Condom, manufactured by Tianjin Condombao Medical Polyurethane Tech. Co. Ltd., is a highly regarded option in the female condom market, known for its dumbbell-shaped polyurethane sheath and accompanying insertion tool, lubricant, sanitary towels, and disposal bags. It is approved for sale in the European Economic Area and available in several countries including Brazil, Sri Lanka, China, Kenya, and Mexico. Despite not being FDA-approved, it offers significant benefits such as STI protection and the ability to use with both water-based and oil-based lubricants. The female condom has a perfect use failure rate of 5% and a typical use failure rate of 21% when used correctly. Its design and materials ensure a comfortable and effective barrier against unwanted pregnancy and STIs. For more detailed information, you can visit the Wikipedia page on the Phoenurse Female Condom.

PATH Woman's Condom

The PATH Woman's Condom, developed through a user-centered process involving feedback from diverse regions, is a highly acceptable and pleasurable female condom designed to protect against unintended pregnancy and sexually transmitted infections. It has shown superior performance compared to the FC1 Female Condom, with a 31% total condom failure rate versus 42% for the FC1, and was preferred by twice as many males and 2.6 times as many females in a comparative study. The condom was developed over a six-year period from 1998 to 2003 and has been tested in multiple countries, including China, South Africa, Thailand, and the United States. It is branded as O'lavie(tm) in China and V Condom in South Africa, and its manufacturing and distribution were scaled up with the help of Shanghai Dahua Medical Apparatus Company. The product has been distributed in significant numbers, with over 130,000 units sold across Malawi and Zambia through PSI's efforts. For more detailed information on the PATH Woman's Condom, visit their dedicated resource page.

Reddy Female Condom

The Reddy Female Condom, though not as highly preferred as the Woman's Condom or FC2 in some studies, is still a notable product in the female condom market. In a comparative study, participants preferred the Woman's Condom and FC2 over the Reddy 6, with a significant preference for the Woman's Condom over FC2 (p= .0007). The Reddy condom has been part of clinical evaluations, showing low clinical failure rates, although specific percentages for the Reddy condom were not highlighted in these studies. The product is recognized globally as a female condom option, contributing to the reduction of STIs and unplanned pregnancies. Despite this, it has faced challenges in user preference and market competitiveness. For more detailed guidelines and information, visit the CDC's clinical treatment guidelines.